Oncology specialists from UC San Francisco will present new clinical research findings and cutting-edge treatment strategies at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, ...

Many men with aggressive prostate cancer can experience a high rate of recurrence despite treatment.A new Phase 2 clinical trial at UC Davis ...

New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while ...

AI could eliminate the "postcode lottery" surrounding a life-extending treatment for advanced prostate cancer, researchers ...

Researchers used ArteraAI to identify 25% of prostate cancer patients in a large trial cohort for whom abiraterone halved the ...

The test could help direct prostate cancer patients to the best treatment option for them, researchers behind the findings ...

While the medicine is free on the NHS in England for men with advanced prostate cancer, Giles has spent £20,000 on it. He ...

The test, developed by Artera, uses AI to pick up features invisible to the human eye on images of tumour samples.

A total of 11 men with high-risk prostate cancer and certain biomarkers, specifically gene mutations, took part in the study. Each patient received 200 mg of niraparib daily for 90 days before ...

At that point, additional blood and urine tests can spot biomarkers that may give a better indication if cancer is present, says Michael S. Leapman, M.D., a urologic oncologist at Yale Medicine. “They ...